Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 5765

1.

Antipsychotics for fibromyalgia in adults.

Walitt B, Klose P, Üçeyler N, Phillips T, Häuser W.

Cochrane Database Syst Rev. 2016 Jun 2;(6):CD011804. doi: 10.1002/14651858.CD011804.pub2. Review.

PMID:
27251337
2.

Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study.

Lee CW, Lin CL, Sung FC, Liang JA, Kao CH.

J Clin Psychiatry. 2016 Jan;77(1):117-22; quiz 122. doi: 10.4088/JCP.14m09580.

3.

Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.

Fawcett J, Rush AJ, Vukelich J, Diaz SH, Dunklee L, Romo P, Yarns BC, Escalona R.

Am J Psychiatry. 2016 Feb 1;173(2):107-11. doi: 10.1176/appi.ajp.2015.15060788. No abstract available.

PMID:
26844792
4.

[Cognitive dysfunction in major depression].

Messer T.

MMW Fortschr Med. 2015 Sep 24;157(16):63-4. German. No abstract available.

PMID:
26783629
5.

Paroxetine and Study 329: what we already knew and when.

Sasich LD.

BMJ. 2015 Oct 14;351:h5411. doi: 10.1136/bmj.h5411. No abstract available.

PMID:
26468042
6.

Authors' reply to Sasich and Linden.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Oct 14;351:h5412. doi: 10.1136/bmj.h5412. No abstract available.

PMID:
26467813
7.

Restoring Study 329: results differ with the adverse event classification system used.

Linden DE.

BMJ. 2015 Oct 14;351:h5413. doi: 10.1136/bmj.h5413. No abstract available.

PMID:
26467710
8.

Strategic use of new generation antidepressants for depression: SUN(^_^) D protocol update and statistical analysis plan.

Yonemoto N, Tanaka S, Furukawa TA, Kato T, Mantani A, Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Shinohara K, Miki K, Inagaki M, Shimodera S, Akechi T, Yamada M, Watanabe N, Guyatt GH; SUN(^_^)D Investigators.

Trials. 2015 Oct 14;16:459. doi: 10.1186/s13063-015-0985-6.

9.

The association between suicidality and treatment with selective serotonin reuptake inhibitors in older people with major depression: a systematic review.

KoKoAung E, Cavenett S, McArthur A, Aromataris E.

JBI Database System Rev Implement Rep. 2015 Apr 17;13(3):174-205. doi: 10.11124/jbisrir-2015-2272. Review.

PMID:
26447056
10.

Modern indications for the use of opipramol.

Krysta K, Murawiec S, Warchala A, Zawada K, Cubała WJ, Wiglusz MS, Jakuszkowiak-Wojten K, Krzystanek M, Krupka-Matuszczyk I.

Psychiatr Danub. 2015 Sep;27 Suppl 1:S435-7. Review.

PMID:
26417811
11.

Hyponatraemia and confusion in a 70-year-old female when bupropion was added to dothiepin and escitalopram.

Wiggins A, Balasubramanian T, Ferraro A.

Australas Psychiatry. 2015 Oct;23(5):507-9. doi: 10.1177/1039856215597534.

PMID:
26405241
12.

Multivariate Statistical Analysis as a Supplementary Tool for Interpretation of Variations in Salivary Cortisol Level in Women with Major Depressive Disorder.

Dziurkowska E, Wesolowski M.

ScientificWorldJournal. 2015;2015:987435. doi: 10.1155/2015/987435. Epub 2015 Aug 25.

13.

Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.

BMJ. 2015 Sep 16;351:h4320. doi: 10.1136/bmj.h4320.

14.

Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis.

Galling B, Calsina Ferrer A, Abi Zeid Daou M, Sangroula D, Hagi K, Correll CU.

Expert Opin Drug Saf. 2015 Oct;14(10):1587-608. doi: 10.1517/14740338.2015.1085970. Epub 2015 Sep 10. Review.

PMID:
26360500
15.

Tobacco Consumption Concerns With the Use of CYP1A2 Metabolized Antidepressants.

Gressier F, Rotenberg S, Ait Tayeb AE, Colle R, Hardy P, Becquemont L, Verstuyft C, Corruble E.

Am J Psychiatry. 2015 Sep 1;172(9):909-10. doi: 10.1176/appi.ajp.2015.15010033. No abstract available.

PMID:
26324305
16.

Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters.

Guo T, Xiang YT, Xiao L, Hu CQ, Chiu HF, Ungvari GS, Correll CU, Lai KY, Feng L, Geng Y, Feng Y, Wang G.

Am J Psychiatry. 2015 Oct;172(10):1004-13. doi: 10.1176/appi.ajp.2015.14050652. Epub 2015 Aug 28.

PMID:
26315978
17.

Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a.

Serchov T, Clement HW, Schwarz MK, Iasevoli F, Tosh DK, Idzko M, Jacobson KA, de Bartolomeis A, Normann C, Biber K, van Calker D.

Neuron. 2015 Aug 5;87(3):549-62. doi: 10.1016/j.neuron.2015.07.010.

18.

Depressive behavior induced by social isolation of predisposed female rats.

Zanier-Gomes PH, de Abreu Silva TE, Zanetti GC, Benati ÉR, Pinheiro NM, Murta BM, Crema VO.

Physiol Behav. 2015 Nov 1;151:292-7. doi: 10.1016/j.physbeh.2015.07.026. Epub 2015 Jul 21.

PMID:
26209499
19.

Common Questions About the Pharmacologic Management of Depression in Adults.

Kovich H, DeJong A.

Am Fam Physician. 2015 Jul 15;92(2):94-100. Review.

20.

Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study.

Yoo I, Woo JM, Lee SH, Fava M, Mischoulon D, Papakostas GI, Kim EJ, Chung S, Ha JH, Jeon HJ.

J Affect Disord. 2015 Oct 1;185:24-30. doi: 10.1016/j.jad.2015.06.038. Epub 2015 Jun 25.

PMID:
26142691
Items per page

Supplemental Content

Loading ...
Write to the Help Desk